In recent trading session, Exact Sciences Corporation (NASDAQ:EXAS) saw 8,899,819 shares changing hands with its beta currently measuring 1.62. Company’s recent per share price level of $94.77 trading at $20.42 or 27.46% at recent trade assigns it a market valuation of $14.21 Billion. That current trading price of EXAS’s stock is at a discount of -11.39% from its 52-week high price of $105.56 and is indicating a premium of 62.8% from its 52-week low price of $35.25. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.57 Million shares which gives us an average trading volume of 1.42 Million if we extend that period to 3-months.

Exact Sciences Corporation (NASDAQ:EXAS) trade information

Upright in the green today for gaining 27.46%, in the last five days EXAS remained trading in the green while hitting it’s week-highest on Thursday, Sep 24 when the stock touched $95.50- price level, adding 3.62% to its value on the day. Exact Sciences Corporation’s shares saw a change of -0.48% in year-to-date performance and have moved 22.9% in past 5-day. Exact Sciences Corporation (NASDAQ:EXAS) showed a performance of 14.75% in past 30-days. Number of shares sold short was 13.17 Million shares which calculate 9.27 days to cover the short interests.

Exact Sciences Corporation (EXAS) estimates and forecasts

Statistics highlight that Exact Sciences Corporation is scoring comparatively higher than the scores of other players of the relevant industry. The company added +21.43% of value to its shares in past 6 months, showing an annual growth rate of 42.95% while that of industry is 14.3. Apart from that, the company came lowering its revenue forecast for fiscal year 2020. The company is estimating its revenue growth to decline by -71% in the current quarter and calculating -181.5% decline in the next quarter. This year revenue growth is estimated to rise 54.3% from the last financial year’s standing.

13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $338.98 Million for the same. And 13 analysts are in estimates of company making revenue of $393.97 Million in the next quarter that will end in December 01, 2020. Company posted $218.81 Million and $295.57 Million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 54.9% while estimating it to be 33.3% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 12.5% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 55.4% while estimates for its earnings growth in next 5 years are of 0%